Discover key advantages of PAE
KEY ADVANTAGES
PAE is a safe treatment option for men with benign prostatic hyperplasia (BPH) and, like other minimally invasive procedures, has significant advantages over conventional open surgery. One year after PAE, average prostate size is seen to shrink by approximately 30%, easing urinary symptoms, sparing erectile function, and increasing quality of life. Men who’ve undergone PAE have reported experiencing a high degree of satisfaction, which was also sustained over one year following the procedure. 1,2
A NUMBER OF BENEFITS
- Minimally invasive procedure
- Virtually no blood loss
- Typically performed as an outpatient procedure
- Offers a shorter hospital stay and a faster recovery time when compared to surgery 3
- Less likely to require urethral catheterization in comparison to surgery 4
- Relieves lower urinary tract symptoms (LUTS) such as feelings of urgency and frequency especially at night (nocturia), incomplete bladder emptying, weak urine stream, intermittency, and straining while urinating 5
- Can improve LUTS without surgery and with lower risk of sexual side effects or incontinence 5
- Overall significant improvement in quality of life
- Can be used without limits on prostate size, urethral narrowing, or bladder capacity. 3,6,7
REFERENCES:
- Carnevale, F. C., da Motta-Leal- Filho, J. M., MD, Antunes, A. A., Baroni, R. H., Marcelino, A. S. Z., Cerri, L. M. O., Yoshinaga, E. M., MD, Cerri, G. G., & Srougi, M. (2013). Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia. Journal of Vascular and Interventional Radiology, 24(4): 535-542. doi: 10.1016/j.jvir.2012.12.019
- Grosso, M., Balderi, A., Arno, M., Sortino, D., Antonietti, A., Pedrazzini, F., Giovinazzo, G., Vinay, C., Maugeri, O., Ambruosi, C., Arena, G. (2015). Prostatic artery embolization in benign prostatic hyperplasia: preliminary results in 13 patients. La Radiologia Medica, 120: 361–368. doi: 10.1007/s11547-014- 0447-3
- Gao, Y. A., Huang, Y., Zhang, R., Yang, Y. D., Zhang, Q., Hou, M., & Wang, Y. (2014). Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate– a prospective, randomized, and controlled clinical trial. Radiology, 270(3): 920-928. doi: 10.1148/radiol.13122803
- McWilliams, J. P., Kuo, M. D., Rose, S.C., Bagla, S., Caplin, D. M., Cohen, E. I., Faintuch, S., Spies, J. B., Saad, W. E., Nikolic, B. (2014). Society of Interventional Radiology position statement: prostate artery embolization for treatment of benign disease of the prostate. Journal of Vascular and Interventional Radiology, 25: 1349-1351. http://dx.doi.org/10.1016/j.jvir.2014.05.005 http://www.scvir.org/clinical/cpg/SIR_Pos_Statmt_PAE_Benign_dis_Prostate.pdf
- Pisco, J., Pinheiro, L. C., Bilhim, T., Duarte, M., Tinto, H. R., Fernandes, L., Santos, V. V., & Oliveira, A. G. (2013). Prostatic arterial embolization for benign prostatic hyperplasia: short- and intermediate-term results. Radiology, 266(2): 668-77. doi: 10.1148/radiol.12111601
- Bhatia, S., Kava, B., Pereira, K., Kably, I., Harward, S., & Narayanan, G. (2015). Prostate artery embolization for giant prostatic hyperplasia. Journal of Vascular and Interventional Radiology. 26(10): 1583-1585. doi: 10.1016/j.jvir.2015.05.024
- Isaacson AJ, et al. Prostatic Artery Embolization using Embosphere Microspheres for Prostates Measuring 80-150cm: Early Results from a US Trial. J Vasc Interv Radiol. 2016 May;27(5):709-14.8
